BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17202328)

  • 1. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage.
    Ganor Y; Teichberg VI; Levite M
    J Immunol; 2007 Jan; 178(2):683-92. PubMed ID: 17202328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration.
    Ganor Y; Besser M; Ben-Zakay N; Unger T; Levite M
    J Immunol; 2003 Apr; 170(8):4362-72. PubMed ID: 12682273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage".
    Poulopoulou C
    J Immunol; 2008 Feb; 180(4):2007; author reply 2007. PubMed ID: 18250401
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
    J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
    Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
    J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?
    Levite M; Hermelin A
    J Autoimmun; 1999 Aug; 13(1):73-82. PubMed ID: 10441170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.
    Ganor Y; Grinberg I; Reis A; Cooper I; Goldstein RS; Levite M
    Leuk Lymphoma; 2009 Jun; 50(6):985-97. PubMed ID: 19391040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.
    Cohen-Kashi Malina K; Ganor Y; Levite M; Teichberg VI
    Neurochem Res; 2006 Oct; 31(10):1181-90. PubMed ID: 16967334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
    Sarchielli P; Di Filippo M; Candeliere A; Chiasserini D; Mattioni A; Tenaglia S; Bonucci M; Calabresi P
    J Neuroimmunol; 2007 Aug; 188(1-2):146-58. PubMed ID: 17628700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) associate with some cognitive/psychiatric/behavioral abnormalities in epilepsy patients.
    Goldberg-Stern H; Ganor Y; Cohen R; Pollak L; Teichberg V; Levite M
    Psychoneuroendocrinology; 2014 Feb; 40():221-31. PubMed ID: 24485494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior.
    Ganor Y; Goldberg-Stern H; Cohen R; Teichberg V; Levite M
    Psychoneuroendocrinology; 2014 Apr; 42():106-17. PubMed ID: 24636507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
    Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
    Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation.
    Gahring L; Carlson NG; Meyer EL; Rogers SW
    J Immunol; 2001 Feb; 166(3):1433-8. PubMed ID: 11160179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
    Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
    Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
    Ganor Y; Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):983-1006. PubMed ID: 24584970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation.
    Carlson NG; Gahring LC; Twyman RE; Rogers SW
    J Biol Chem; 1997 Apr; 272(17):11295-301. PubMed ID: 9111034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of GluR3 receptors tagged with GFP at the amino or carboxyl terminus.
    Limon A; Reyes-Ruiz JM; Eusebi F; Miledi R
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15526-30. PubMed ID: 17881566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.
    Peacock JW; Jirik FR
    J Immunol; 1999 Jan; 162(1):215-23. PubMed ID: 9886389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.